Facts and trends in laparoscopic gastrectomy for cancer

Surgical Endoscopy

Volumn 23, Issue 12, 2009, Pages 2867-2869

  Kanellos, D ^a   Pramateftakis, M G ^a   Kanellos, Ioannis ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

GASTRECTOMY; GASTRIC BANDING; HOSPITALIZATION; HUMAN; LAPAROSCOPIC SURGERY; MEDICAL LITERATURE; MEDICAL RESEARCH; OPERATION DURATION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; SHORT SURVEY; STOMACH TUMOR;

CLINICAL COMPETENCE; FEMALE; GASTRECTOMY; HUMANS; LAPAROSCOPY; MALE; STOMACH NEOPLASMS;

EID: 71449096321     PISSN: 09302794     EISSN: 14322218     Source Type: Journal    
DOI: 10.1007/s00464-009-0525-0     Document Type: Short Survey

References (36)

1. W Kim KY Song HJ Lee SU Han WJ Hyung GS Cho 2008 The impact of comorbidity on surgical outcomes in laparoscopy-assisted distal gastrectomy: a retrospective analysis of multicenter results Ann Surg 248 793 799 10.1097/SLA.0b013e3181887516 18948806
2. YW Kim YH Baik YH Yun, et al. 2008 Improved quality-of-life outcomes after laparoscopy-assisted distal gastrectomy for early gastric cancer: results of a prospective randomized clinical trial Ann Surg 248 721 727 10.1097/SLA.0b013e318185e62e 18948798
3. Yoo CH, Kim HO, Hwang SI, Son BH, Shin JH, Kim H (2009) Short-term outcomes of laparoscopic-assisted distal gastrectomy for gastric cancer during a surgeon's learning curve period. Surg Endosc [Epub ahead of print]. doi: 10.1007/s00464-008-0315-0
4. DH Roukos AM Kappas 2005 Perspectives in the treatment of gastric cancer Nat Clin Pract Oncol 2 98 107 10.1038/ncponc0099 16264882 (Pubitemid 40790143)
5. DH Roukos 1999 Current advances and changes in treatment strategy may improve survival and quality of life in patients with potentially curable gastric cancer Ann Surg Oncol 6 46 56 10.1007/s10434-999-0046-z 1:STN:280:DyaK1M7ltlCrtA%3D%3D 10030415 (Pubitemid 29077488)
6. DH Roukos AM Kappas 2002 Targeting the optimal extent of lymph node dissection for gastric cancer J Surg Oncol 81 59 62 10.1002/jso.10153 12355403
7. AM Kappas M Fatouros DH Roukos 2004 Is it time to change surgical strategy for gastric cancer in the United States? Ann Surg Oncol 11 727 730 10.1245/ASO.2004.05.907 15249337 (Pubitemid 40486685)
8. DH Roukos 1998 Extended lymphadenectomy in gastric cancer: when, for whom and why Ann R Coll Surg Engl 80 16 24 1:STN:280:DyaK1c3ktVartw%3D%3D 9579122
9. DH Roukos 2000 Extended (D2) lymph node dissection for gastric cancer: do patients benefit? Ann Surg Oncol 7 253 255 10.1007/s10434-000-0253-0 1:STN:280:DC%2BD3c3nslGitg%3D%3D 10819363
10. DH Roukos C Hottenrott M Lorenz S Koutsogiorgas-Couchell 1990 A critical evaluation of effectivity of extended lymphadenectomy in patients with carcinoma of the stomach: an analysis of early results and long-term survival J Cancer Res Clin Oncol 116 307 311 10.1007/BF01612909 1:STN:280:DyaK3czhs12nsA%3D%3D 2370254 (Pubitemid 20299176)
11. DH Roukos P Paraschou M EnLorenzcke 2000 Distal gastric cancer and extensive surgery: a new evaluation method based on the study of the status of residual lymph nodes after limited surgery Ann Surg Oncol 7 10 719 726 10.1007/s10434-000-0719-0 1:STN:280:DC%2BD3M7gsV2nsw%3D%3D 11129418
12. DH Roukos C Hottenrott A Encke G Baltogiannis D Casioumis 1994 Primary gastric lymphomas: a clinicopathologic study with literature review Surg Oncol 3 115 125 10.1016/0960-7404(94)90007-8 1:STN:280:DyaK2M%2FktVWitQ%3D%3D 7952391 (Pubitemid 24237139)
13. DH Roukos 2004 Early-stage gastric cancer: a highly treatable disease Ann Surg Oncol 11 127 129 10.1245/ASO.2004.11.903 14761914 (Pubitemid 40486786)
14. T Liakakos DH Roukos 2008 More controversy than ever: challenges and promises towards personalized treatment of gastric cancer Ann Surg Oncol 15 956 960 10.1245/s10434-007-9798-5 18214617
15. AM Kappas DH Roukos 2002 Quality of surgery determinant for the outcome of patient with gastric cancer Ann Surg Oncol 9 828 830 10.1007/BF02557517 12417502
16. DH Roukos M Lorenz K Karakostas P Paraschou C Batsis AM Kappas 2001 Pathological serosa and node-based classification accurately predicts gastric cancer recurrence risk and outcome, and determines potential and limitation of a Japanese-style extensive surgery for Western patients: a prospective with quality control 10-year follow-up study Br J Cancer 84 1602 1609 10.1054/bjoc.2001.1720 1:STN:280:DC%2BD3MzjsVSgtA%3D%3D 11401312 (Pubitemid 32612490)
17. E Briasoulis M Fatouros DH Roukos 2007 Level I evidence in support of perioperative chemotherapy for operable gastric cancer: sufficient for wide clinical use? Ann Surg Oncol 14 2691 2695 17653806
18. DH Roukos 2002 Adjuvant chemoradiotherapy in gastric cancer: wave goodbye to extensive surgery? Ann Surg Oncol 9 220 221 10.1007/BF02573057 11923126
19. E Briasoulis T Liakakos L Dova, et al. 2006 Selecting a specific pre- or postoperative adjuvant therapy for individual patients with operable gastric cancer Expert Rev Anticancer Ther 6 931 939 10.1586/14737140.6.6.931 16761937 (Pubitemid 44201562)
20. DH Roukos 2009 Assessing both genetic variation (SNPs/CNVs) and gene-environment interactions may lead to personalized gastric cancer prevention Expert Rev Mol Diagn 9 1 6 10.1586/14737159.9.1.1 1:CAS:528:DC%2BD1cXhsFajsrnE 19099341
21. DH Roukos 2009 Genome-wide association studies and aggressive surgery toward individualized prevention, and improved local control and overall survival for gastric cancer Ann Surg Oncol 16 4 795 798 10.1245/s10434-009-0317- 8 19169753
22. D Ziogas G Baltogiannis M Fatouros DH Roukos 2008 Identifying and preventing high-risk gastric cancer individuals with CDH1 mutations Ann Surg 247 714 715 10.1097/SLA.0b013e31816a5072 18362641
23. M Fatouros G Baltoyiannis DH Roukos 2008 The predominant role of surgery in the prevention and new trends in the surgical treatment of women with BRCA1/2 mutations Ann Surg Oncol 15 21 33 10.1245/s10434-007-9612-4 17940826
24. NJ Agnantis E Paraskevaidis D Roukos 2004 Preventing breast, ovarian cancer in BRCA carriers: rational of prophylactic surgery and promises of surveillance Ann Surg Oncol 11 1030 1034 10.1245/ASO.2004.09.910 15545500 (Pubitemid 40486647)
25. DH Roukos NJ Agnanti E Paraskevaidis AM Kappas 2002 Approaching the dilemma between prophylactic bilateral mastectomy or oophorectomy for breast and ovarian cancer prevention in carriers of BRCA1 or BRCA2 mutations Ann Surg Oncol 9 941 943 12464584
26. DH Roukos 2008 Genetics and genome-wide association studies: surgery-guided algorithm and promise for future breast cancer personalized surgery Expert Rev Mol Diagn 8 587 597 10.1586/14737159.8.5.587 18785807
27. DH Roukos E Lykoudis T Liakakos 2008 Genomics and challenges toward personalized breast cancer local control J Clin Oncol 26 4360 4361 10.1200/JCO.2008.18.6197 18779627
28. DH Roukos 2008 HER2 and response to paclitaxel in node-positive breast cancer N Engl J Med 358 197 10.1056/NEJMc073152 1:CAS:528:DC%2BD1cXltFKhsQ%3D%3D 18193530
29. DH Roukos 2008 Breast-cancer stromal cells with TP53 mutations N Engl J Med 358 1636 10.1056/NEJMc073152 1:CAS:528:DC%2BD1cXks1Wjtbc%3D 18411428
30. DH Roukos 2008 Linking contralateral breast cancer with genetics Radiother Oncol 86 139 141 10.1016/j.radonc.2008.01.013 18237805
31. DH Roukos 2009 Personal genomics and genome-wide association studies: novel discoveries but limitations for practical personalized medicine Ann Surg Oncol 16 772 773 10.1245/s10434-008-0109-6 18726130
32. DH Roukos D Ziogas 2009 Human genetic and structural genomic variation: would genome-wide association studies be the solution for cancer complexity like Alexander the Great for the "Gordian knot"? Ann Surg Oncol 16 774 775 10.1245/s10434-008-0056-2 18612696
33. DH Roukos 2008 Innovative genomic-based model for personalized treatment of gastric cancer: integrating current standards and new technologies Expert Rev Mol Diagn 8 29 39 10.1586/14737159.8.1.29 1:CAS:528:DC%2BD2sXhsVCgtr7P 18088228
34. DH Roukos 2009 Personalized cancer diagnostics and therapeutics Expert Rev Mol Diagn 9 3 227 229 10.1586/erm.09.6 19379081
35. DH Roukos 2009 Mea Culpa with cancer-targeted therapy: new thinking and new agents design for novel, causal networksbased, personalized biomedicine Expert Rev Mol Diagn 9 3 217 221 10.1586/erm.09.7 19379079
36. DH Roukos 2009 Genome-wide association studies: how predictable is a person's cancer risk? Expert Rev Anticancer Ther 9 4 389 392 10.1586/era.09.12 19374592